Preethi Sundaram - 15 Sep 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Chief Strategy Officer
Signature: /s/ Preethi Sundaram
Issuer symbol: CPRX
Transactions as of: 15 Sep 2022
Net transactions value: -$163,926
Form type: 4
Filing time: 16 Sep 2022, 17:01:04 UTC
Previous filing: 16 Feb 2022
Next filing: 15 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CPRX	Common stock, par value $0.001 per share	Options Exercise	$99,995	+18,214		$5.49	18,214	15 Sep 2022	Direct
transaction	CPRX	Common stock, par value $0.001 per share	Sale	$263,921	-18,214	-100%	$14.49	0	15 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Options to purchase common stock	Options Exercise	$0	+18,214	+4.8%	$0.000000	399,286	15 Sep 2022	Common Stock	18,214	$5.49	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were sold for personal reasons and not as a result of any disagreement with the Registrant. Dr. Sundaram remains an officer of the Company.